Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q4 2020 (Next →)
Filing Date: Feb 12, 2021
Total Value: $189M (97.9% shares, 2.1% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | EIDOS THERAPEUTICS INC | 225,000 | $29.61M | 15.7% | $131.58 | — | COM | 28249H104 |
| SPY | SPDR S&P 500 ETF TRUST TRUST | 40,000 | $14.96M | 7.9% | — | — | Put | 78462F103 |
| — | CURIS INC | 1,450,000 | $11.88M | 6.3% | $8.19 | — | COM | 231269200 |
| BBIO | BRIDGEBIO PHARMA INC | 155,000 | $11.02M | 5.8% | $48.24 | 0.0% | COM | 10806X102 |
| KURA | KURA ONCOLOGY INC | 260,000 | $8.492M | 4.5% | $35.14 | 0.0% | COM | 50127T109 |
| — | VINCERA PHARMA INC | 403,000 | $8.427M | 4.5% | $20.91 | — | COM | 92731L106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 105,000 | $5.758M | 3.1% | $36.45 | 0.0% | COM | 77313F106 |
| — | ACCELERON PHARMA INC | 45,000 | $5.757M | 3.1% | $127.93 | — | COM | 00434H108 |
| OCUL | OCULAR THERAPEUTIX INC | 220,000 | $4.554M | 2.4% | $14.85 | 0.0% | COM | 67576A100 |
| — | CEREVEL THERAPEUTICS HOLDINGS I | 270,000 | $4.477M | 2.4% | $16.58 | — | COM | 15678U128 |
| — | SUTRO BIOPHARMA INC | 200,000 | $4.342M | 2.3% | $21.71 | — | COM | 869367102 |
| — | RETROPHIN INC | 4,000,000 | $4.035M | 2.1% | $1.01 | — | NOTE 2.500 9/15/2025 | 761299AB2 |
| ARKG | ARK ETF TR | 40,000 | $3.73M | 2.0% | — | — | Put | 00214Q302 |
| IMVT | IMMUNOVANT INC | 75,000 | $3.464M | 1.8% | $46.23 | 0.0% | COM | 45258J102 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 150,500 | $3.347M | 1.8% | — | — | Call | 87164F105 |
| — | HORIZON THERAPEUTICS PLC | 45,000 | $3.292M | 1.7% | $73.16 | — | SHS | G46188101 |
| — | ARYA SCIENCES ACQUISITION CO | 300,000 | $3.255M | 1.7% | $10.85 | — | COM CL A | G3166W106 |
| — | LIFESCI ACQUISITION II CORP | 300,000 | $3.201M | 1.7% | $10.67 | — | COM | 53229E103 |
| — | ZYMEWORKS INC | 65,000 | $3.072M | 1.6% | $47.26 | — | COM | 98985W102 |
| — | HEALTH SCIENCES ACQUISITIONS CORP 2 | 200,000 | $2.562M | 1.4% | $12.81 | — | ORD SHS | G4411D109 |
| — | CHINOOK THERAPEUTICS INC | 150,000 | $2.379M | 1.3% | $15.86 | — | COM | 16961L106 |
| VRTX | VERTEX PHARMACEUTICALS INC | 10,000 | $2.363M | 1.3% | $229.44 | 0.0% | COM | 92532F100 |
| — | MORPHIC HOLDING INC | 67,500 | $2.265M | 1.2% | $33.56 | — | COM | 61775R105 |
| MREO | MEREO BIOPHARMA GROUP PLC | 625,000 | $2.238M | 1.2% | $3.58 | — | ADS | 589492107 |
| — | ATHENEX INC | 200,000 | $2.212M | 1.2% | $11.06 | — | COM | 04685N103 |
| — | MIRATI THERAPEUTICS INC | 10,000 | $2.196M | 1.2% | $219.60 | — | COM | 60468T105 |
| — | GLOBAL BLOOD THERAPEUTICS INC | 50,000 | $2.166M | 1.1% | $43.32 | — | COM | 37890U108 |
| AXSM | AXSOME THERAPEUTICS INC | 25,000 | $2.037M | 1.1% | $74.78 | 0.0% | Call | 05464T104 |
| — | LEAP THERAPEUTICS INC | 904,600 | $2.035M | 1.1% | $2.25 | — | COM | 52187K101 |
| — | SOLID BIOSCIENCES INC | 250,000 | $1.895M | 1.0% | — | — | Call | 83422E105 |
| ASND | ASCENDIS PHARMA A/S | 10,000 | $1.668M | 0.9% | $166.80 | — | SPONSORED ADR | 04351P101 |
| MGTX | MEIRAGTX HOLDINGS PLC | 100,000 | $1.514M | 0.8% | $14.13 | 0.0% | COM | G59665102 |
| — | LONGVIEW ACQUISITION CORP | 75,000 | $1.484M | 0.8% | $19.79 | — | COM CL A | 543195101 |
| CYTK | CYTOKINETICS INC | 70,000 | $1.455M | 0.8% | $18.28 | 0.0% | COM | 23282W605 |
| LUNG | PULMONX CORPORATION | 20,000 | $1.38M | 0.7% | $48.97 | 0.0% | COM | 745848101 |
| — | MERSANA THERAPEUTICS INC | 50,000 | $1.331M | 0.7% | $26.62 | — | COM | 59045L106 |
| CLDX | CELLDEX THERAPEUTICS INC | 75,000 | $1.314M | 0.7% | $18.00 | 0.0% | COM | 15117B202 |
| — | PANDION THERAPEUTICS INC | 80,000 | $1.188M | 0.6% | $14.85 | — | COM | 698340106 |
| — | BCTG ACQUISITION CORP | 100,000 | $1.144M | 0.6% | $11.44 | — | COM | 05492W103 |
| — | VESPER HEALTHCARE ACQUISITION CORP | 100,000 | $1.131M | 0.6% | $11.31 | — | COM CL A | 92538T104 |
| — | CYCLACEL PHARMACEUTICALS INC | 117,545 | $918K | 0.5% | $7.81 | — | COM | 23254L603 |
| BYSI | BEYONDSPRING INC | 75,000 | $915K | 0.5% | $13.15 | 0.0% | SHS | G10830100 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 19,600 | $909K | 0.5% | $39.70 | 0.0% | COM | 462260100 |
| — | DICERNA PHARMACEUTICALS INC | 40,000 | $881K | 0.5% | $22.02 | — | COM | 253031108 |
| — | INARI MEDICAL INC | 10,000 | $873K | 0.5% | $87.30 | — | COM | 45332Y109 |
| KALV | KALVISTA PHARMACEUTICALS INC | 45,000 | $855K | 0.5% | $17.15 | 0.0% | COM | 483497103 |
| AXSM | AXSOME THERAPEUTICS INC | 10,000 | $815K | 0.4% | $74.78 | 0.0% | COM | 05464T104 |
| PCVX | VAXCYTE INC | 30,000 | $797K | 0.4% | $37.18 | 0.0% | COM | 92243G108 |
| — | CHARDAN HEALTHCARE ACQUISITION 2 CORP | 75,000 | $794K | 0.4% | $10.59 | — | COM | 15957T107 |
| — | IMMATICS N.V | 242,855 | $699K | 0.4% | $2.88 | — | *W EXP 07/01/2025 | N44445117 |
| — | SIO GENE THERAPIES INC | 250,000 | $695K | 0.4% | $2.78 | — | COMMON | 829399104 |
| ALDX | ALDEYRA THERAPEUTICS INC | 100,000 | $686K | 0.4% | $7.02 | 0.0% | COM | 01438T106 |
| CCCC | C4 THERAPEUTICS INC | 20,000 | $663K | 0.4% | $29.00 | 0.0% | COM STK | 12529R107 |
| — | VINCERA PHARMA INC | 190,000 | $627K | 0.3% | $3.30 | — | *W EXP 12/24/2025 | 92731L114 |
| — | LYRA THERAPEUTICS INC | 50,000 | $570K | 0.3% | $11.40 | — | COM | 55234L105 |
| — | OUTSET MEDICAL INC | 10,000 | $568K | 0.3% | $56.80 | — | COM | 690145107 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 5,000 | $556K | 0.3% | $122.23 | 0.0% | COM | 558868105 |
| CRSP | CRISPR THERAPEUTICS AG | 3,500 | $536K | 0.3% | $118.20 | 0.0% | NAMEN AKT | H17182108 |
| — | CEREVEL THERAPEUTICS HOLDINGS I | 72,466 | $409K | 0.2% | $5.64 | — | *W EXP 06/09/2025 | 15678U102 |
| VXRT | VAXART INC | 25,000 | $143K | 0.1% | — | — | Put | 92243A200 |
| — | VESPER HEALTHCARE ACQUISITION CORP | 33,333 | $88,000 | 0.0% | $2.64 | — | *W EXP 09/30/2027 | 92538T112 |
| — | ZYNERBA PHARMACEUTICALS INC | 13,285 | $44,000 | 0.0% | $3.31 | — | COM | 98986X109 |